
Adamis Pharmaceuticals Investor Relations Material
Latest events

Q1 2023
Adamis Pharmaceuticals

Q3 2023
14 Nov, 2023

Q2 2023
21 Aug, 2023
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Adamis Pharmaceuticals Corporation
Access all reports
Adamis Pharmaceuticals Corporation is a specialty biopharmaceutical company focused on developing and commercializing therapeutic products in allergy, respiratory, and opioid overdose treatment. Its portfolio includes prescription medicines and drug-device combination products, such as epinephrine injectors for severe allergic reactions and naloxone for opioid overdose reversal. The company is headquartered in San Diego, California, and its shares are listed on the NASDAQ.
Latest articles
)
Eli Lilly: The Pharma Giant Behind Mounjaro and Zepbound
Eli Lilly's journey from insulin pioneer to global pharma giant, leading innovation in diabetes, obesity, and the future of metabolic health.
30 Jun 2025
)
500 Years of Craft, One Family Legacy: Beretta Holding's Global Expansion
How Beretta Holding managed to transform from a 16th-century gun barrel producer into a global industrial group while preserving 500 years of legacy.
27 Jun 2025
)
Shuntaro Furukawa: The Sixth President of Nintendo
Shuntaro Furukawa, Nintendo's sixth president, went from a childhood fan to leading the company through global expansion and the launch of Switch 2.
23 Jun 2025
Ticker symbol
ADMP
Country
🇺🇸 United States